Full Version -
In 2008 the WHO Classifications for haematological malignancies were re-classified. Since 2008, there has been new evolving technologies and subtypes. The presentation will review the 2008 WHO Classifications and the technology that was used for these classifications. Then the presentation will focus on the discussion of today’s new technologies and how new subtypes have emerge in the laboratories. Genetic technology is explored as the diagnostic tool of these subtypes and how this technology has improved diagnosis and possible patient treatments.
- Review of the WHO Classifications and the technology of 2008 will be discussed.
- A review of the changing technology for these malignancies will be explored.
- A discussion of how genetic technology has improved subclasses and possible diagnosis of the malignancies.
- Review of the current status of genetic testing and technology for heamatological malignancies subclasses.
Leica Biosystems webinars, training presentations and related materials provide general information regarding particular subjects and are not intended to be, and should not be construed as medical, regulatory or legal advice. The views and opinions expressed are the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents.
For the use of any product, the product information guides, inserts and operation manuals of the various products and devices should be consulted. Leica Biosystems and the editors disclaim any liability arising directly or indirectly from the use of devices, techniques or procedures described in these materials.
Copyright © 2019 by Leica Biosystems Richmond Inc. All rights reserved.LEICA and the Leica Logo are registered trademarks of Leica Microsystems